Argyle Capital Management Inc. Viatris Inc Transaction History

Argyle Capital Management Inc.

$255 Million
Q1 2024

A detailed history of Argyle Capital Management Inc. transactions in Viatris Inc stock. As of the latest transaction made, Argyle Capital Management Inc. holds 10,059 shares of VTRS stock, worth $108,637. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,059

Previous 10,413 3.4%

Holding current value

$108,637

Previous $112,000 7.14%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$11.27 - $13.53 $3,989 - $4,789	-354 Reduced 3.4%	10,059 $120,000
Q4 2023 Feb 05, 2024	SELL	$8.77 - $10.85 $19,837 - $24,542	-2,262 Reduced 17.85%	10,413 $112,000
Q3 2023 Oct 26, 2023	SELL	$9.59 - $11.35 $949 - $1,123	-99 Reduced 0.78%	12,675 $124,000
Q2 2023 Jul 27, 2023	SELL	$9.02 - $10.29 $18,346 - $20,929	-2,034 Reduced 13.74%	12,774 $127,000
Q1 2023 Apr 27, 2023	SELL	$9.2 - $12.26 $1,821 - $2,427	-198 Reduced 1.32%	14,808 $142,000

Q3 2022 Oct 21, 2022	SELL	$8.48 - $11.13 $737 - $968	-87 Reduced 0.58%	15,006 $128,000
Q2 2022 Jul 20, 2022	SELL	$9.95 - $12.27 $10,238 - $12,625	-1,029 Reduced 6.38%	15,093 $158,000
Q1 2022 Apr 27, 2022	SELL	$9.81 - $15.4 $5,218 - $8,192	-532 Reduced 3.19%	16,122 $175,000
Q4 2021 Jan 25, 2022	SELL	$12.09 - $14.68 $5,984 - $7,266	-495 Reduced 2.89%	16,654 $225,000
Q3 2021 Oct 25, 2021	SELL	$13.25 - $15.13 $4,902 - $5,598	-370 Reduced 2.11%	17,149 $232,000
Q2 2021 Jul 27, 2021	SELL	$12.97 - $16.15 $3,929 - $4,893	-303 Reduced 1.7%	17,519 $250,000
Q1 2021 Apr 27, 2021	SELL	$13.59 - $18.54 $3,016 - $4,115	-222 Reduced 1.23%	17,822 $249,000
Q4 2020 Jan 28, 2021	BUY	$14.3 - $18.74 $258,029 - $338,144	18,044 New	18,044 $338,000

Others Institutions Holding VTRS

# of Institutions

1,103

Shares Held

945M

Call Options Held

3.49M

Put Options Held

2.6M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.1B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.

Account

Argyle Capital Management Inc. Viatris Inc Transaction History